Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Language
Publication year range
1.
Rev Neurol ; 33(5): 413-6, 2001.
Article in Spanish | MEDLINE | ID: mdl-11727205

ABSTRACT

INTRODUCTION: Thymectomy is a well established procedure in myasthenia gravis (MG). To reduce its morbidity, treatments which are effective in the short term, such as plasmapheresis and intravenous immunoglobulin (IGI) have been used. OBJECTIVE: To evaluate the efficacy and tolerability of the IGI, compared with plasmapheresis, in the preparation of myasthenic patients before thymectomy. PATIENTS AND METHODS: We compared a group of 33 prospective myasthenic patients treated with IGI with 38 clinical histories taken as controls treated by plasmapheresis during the peri operative period of thymectomy. RESULTS: The patients treated with IGI were in the intensive care unit and neurology ward for less time. The endotracheal tube was also removed sooner. However, these differences were not significant. The commonest complications of IGI were fever, shivering and phlebitis. The most frequent adverse reaction to plasmapheresis were cutaneous eruptions. One patient developed Hepatitis C after plasmapheresis. CONCLUSION: IGI is comparable in efficacy to plasmapheresis in the peri operative period of MG, but has a better profile of adverse reactions.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Immunoglobulins, Intravenous/therapeutic use , Myasthenia Gravis/drug therapy , Myasthenia Gravis/surgery , Plasmapheresis/methods , Postoperative Care , Prednisone/therapeutic use , Preoperative Care , Thymectomy/methods , Adult , Female , Humans , Male , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL